Viewing Study NCT03855358


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-01-11 @ 12:58 AM
Study NCT ID: NCT03855358
Status: UNKNOWN
Last Update Posted: 2019-10-30
First Post: 2019-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module